{"id":"W2161021913","doi":"10.3324/haematol.2014.115840","title":"Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Stanford Cancer Institute; National Heart, Lung, and Blood Institute; University of Texas MD Anderson Cancer Center; Weill Cornell Medical College; University of California, Los Angeles; Monash University; Hollings Cancer Center, Medical University of South Carolina; Northwestern University; Incyte; NIH Clinical Center; Townsville Hospital and Health Service; Emory University; Huntsman Cancer Institute; University of Toronto; Tower Cancer Research Foundation; London Health Sciences Centre; Barbara Ann Karmanos Cancer Institute; Rush University; University of Louisville; Georgetown University; National Cancer Institute; Wake Forest University; Kaiser Permanente; Cleveland Clinic; George Washington University; University of Pennsylvania; Vanderbilt University; University of Southern California; Park Nicollet Foundation","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Internal medicine; Oncology; Surgery; Bone marrow","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002471001,0.0002138635,0.0009332069,0.0001138981,0.00002630321,0.000005878685,0.00006888874,0.00009999642,0.00002128151],"category_scores_gemma":[0.0002445794,0.0001213314,0.00004175361,0.0002340451,0.0002318813,0.00004763173,0.00005050325,0.0001054879,0.000004374324],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003497523,"about_ca_system_score_gemma":0.0001222909,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001723386,"about_ca_topic_score_gemma":0.0004300684,"domain_scores_codex":[0.998366,0.00009325219,0.0005138778,0.0003184558,0.0004615191,0.0002468866],"domain_scores_gemma":[0.9987329,0.0002432088,0.0002630363,0.0002907601,0.0002550115,0.0002150483],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02487208,0.0009852959,0.9709768,0.0001031196,0.0001521903,0.00008672645,0.0009409885,0.00000422202,0.000003276826,0.001044774,0.0001740491,0.0006565365],"study_design_scores_gemma":[0.04756032,0.006610047,0.9425319,0.0007102885,0.0001415655,0.00003315861,0.0005540156,0.000008781849,0.001383675,0.00004838272,0.0002692839,0.0001486013],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939588,0.00007313224,0.000007690863,0.0003938855,0.00003638211,0.0008362248,0.00009902887,0.00002062882,0.004574178],"genre_scores_gemma":[0.9978845,0.00006175807,0.001786823,0.00003281255,0.000009205371,0.00003554472,0.0001194268,0.00001626872,0.00005368002],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02844487,"threshold_uncertainty_score":0.494775,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02592074123617636,"score_gpt":0.2561980427566157,"score_spread":0.2302773015204394,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}